Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Why are people ramping this so hard, makes people more suspicious than anything else
We have ludicrous claims
- 500k to list stemprint
- £2.5++ BILLION valuation
- £10 SP
Feels like there a load of noobs to AIM / investing making wild claims that are totally unfounded.
Zeb the 3 points you call out in your post.
I would imagine you have figures to throw weight behind your bullet points.
We are all ears and await your next post
Zeb I will help you with your 1st one it’s not hard if you go on the aim website.
on the junior market can cost a minimum of £500,000, while core running costs clock in at a minimum of £200,000 per year.
Jadam post recommended
The poster obviously wants in or sold on Friday.
We await zebs thoughts.
Glorious day enjoy all :-)
It is possible that zebbo is just giving a slightly more balanced view to the future outcome. I'd love to see £10 a share price but how many people are now expecting that as a minimum and will be upset if it dosent reach it for one reason or another?
I would rather be overwhelmed by the increase than think higher now and have my whelm well and truly undered if it dosent materialise.
poor outcome TILS £3 with STEM £3 as a whole £6 within 12month
best outcome TILS £5-7 with STEM buyout around $2.5 or $3billion
AT least we can back up our arguments or points of view with facts. Meanwhile Zeb just sings mud.
TILS is with the 2 big company Covid-19 treatments, and TILS has already shown 2 distinct advantages over Roche's Actemra and Regeneron’s Kevzara. Hence why TILS has had to file the patent for this treatment very quickly. They have a major competitive advantage going forward - and none of this has been reflected in the previously over sold prices.
The recent news is that Ventilators are causing permanent lung damage, because they are forcing oxygen in, which is not being totally used by the lungs due to the lung infection. Therefore the infection has to be cleared or the patience dies. TILS targeting drug and procedure (superior) and targets the lungs to clear the infection that is actually causing death. :) / this is home run, considering to major drugs have worked in China and these are intravenous delivery only and do not deliver directly to the lungs. They also caused poor immune responses because they’re humanised and not like TILS drug which is human ready and will not have any impact on human immune system.
TZLS-501 by Tiziana Life Sciences
Tiziana Life Sciences is developing its monoclonal antibody named TZLS-501 for the treatment of COVID-19. TZLS-501 is a human anti-interleukin-6 receptor (IL-6R), which helps in preventing lung damage and elevated levels of IL-6.
The drug works by binding to IL-6R and depleting the amount of IL-6 circulating in the body thereby reducing chronic lung inflammation.
Actemra by Roche to treat coronavirus-related complications
China approved the use of Roche’s Actemra for the treatment of severe complications related to coronavirus. Drugs like Actemra have the ability to prevent cytokine storms or overreaction of the immune system, which is considered as the main reason behind organ failure leading to death in some coronavirus patients.
Actemra is also being evaluated in a clinical trial in China, which is expected to enrol 188 coronavirus patients. The clinical trial is expected to be conducted until May 10.
Regeneron’s REGN3048-3051 and Kevzara
Discovered by Regeneron, the combination of neutralising monoclonal antibodies REGN3048 and REGN3051 is being studied against coronavirus infection in a first-in-human clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). The safety and tolerability of the drug will be studied in 48 patients.
Both the antibodies bind to S-protein of MERS coronavirus. The intravenous administration of the drug in the mouse model of MERS resulted in the high-level neutralisation of the MERS coronavirus in circulating blood with reduced viral loads in the lungs.
Regeneron has partnered with Sanofi to evaluated Kevzara, a fully-human monoclonal antibody, in a phase two/three clinical trial in patients with severe COVID-19 infection. Kevzara is approved for the treatment of rheumatoid arthritis and is known t
Until we see what the value of StemPrintER after the meeting on the 29th May people can speculate what the value might be. No forth coming evaluation was give only that it is presently at "zero book value" . Tuesday will be interesting to see if the sp stalls and waits for the decision.
Do I want to hold new StemPrintER as a separate stock on the LSE and a devalued Tiziana Life Sc on day one or wait until the stock is split and buy into Tiziana Life Sc.?What will be the value and devaluation of Tiziana Life Sc when the split occurs?
MAnabout. Think about your wait and see approach. You can buy now for 100p ish but you think you should wait for 200p? In other words miss out on doubling your investment. If you buy at 200p you will have to wait for 400p before doubling your money but if you buy tomorrow at 100p and wait for 400p then you will have increased your money by 300% not just 100%. I'm not saying either scenario will happen quickly but 200p could happen within the month. Its up to you.
Apologies Manabout. I did mean J427 . Its the heat I think ;-)
Imo its not buy one get one free,its buy one and then that is split in two,but we could argue about this till the cows come home so we will have to just wait and see.
Personally i dont think it will happen,and the 500k to start this new company is so far out ,theres no point in explaining it to those that think that .
You couldnt start a coffeshop for tgat price !!
I think someone was saying ,that these crazy crazy valuations do more damage then good for the company .
“500k to start a company “
It’s not a start up - it’s a separation of an existing business - £500k being listing fees.
Separation, means separate costs ,separate overheads,separate wages ,separate accounting, seperate resources, separate everything,.
Please get real!
You think wrong then!!invested but not wet behind the ears like most on here!!
Surely that tells you the value , they would not double costs if it was not worthwhile
"Free Shares" " zero cost to run a company" "500k to start " (just pluck a figure ) .
The light bulb needs to come on and people wake up to reality.
Any split takes value and devalues the main company. This is reality in the real world of running a company. Business split of parts of there business for a number of reasons. This might not be your main core business which allows additional interest for investors or to be sold and capital returned to your main business.
Jessel ,being honest with ones self of costs is not deramping,if you like pretty pictures and happy stories watch a disney films!!
I think it will do well here but its a 5 year story imo,but yes the next 6 months will be interesting, infact tomorrow will be interesting.
Some people need some business basics. Take off those rose tinted specs for a minute
The split will need to be funded by TILS, 500k will NOT get them a separate listing. You need at least 12 months working capital for starters and thats just AIM
Jessel also you need to be versatile, news changes ever day,so do opinions,
Wele see tomorrow,
Wild shot in the dark wele test 104 and possibly the 80s tomorrow!!
Zeb I’m still waiting for your 3 bullet point figures or are you still full of puff and wind and no substance.
Drlong you sound very desperate to get back In :-))))
asher7, why would I spend my time answering dumb questions, when you cannot get the basic listing criteria right.
Sounding rather desperate yourself...:-))
Bimey, it's not fun reading all this....
I personally think the move to splitting the company for StemPrintER is a shrewd red herrinng by Gabriele.
It brings the focus to where he wants on where he believes it's undervalued/appreciated. This announcment has changed all that and if SP was to stay within the same company, they would need more than the $10M they gave now.
Hence, this recent RNS on 15/4 which shows how they could raise $20M if they wish to................
The shares being reserved under this block listing will be issued with the intention to satisfy the "At the Market" or "ATM" Sales Agreement with Think Equity (a division of Fordham Financial Management, Inc.) to raise up to US$20m from the sale of ADSs (each representing 5 new ordinary shares) pursuant to the following scheme:.........
Either way, he has achieved the focus on SM to enhance its value, in one day.
I don't really care too much if it splits or not, personal preference is to keep as is now, but either way this feels a no brainer investment and while some of you wait or argue, I think the share price willl move onto £1.20 by the end of the week.
The markets are up today as are the futures, so it looks like a promising start tomorrow.
BTW, I do personally think that overly ramp the share price and value of the company is a bit of a put of and can be as detrimental as shorters comments. GLA tomorrow
PS. sorry for so many typos, was rushing before dinner!!
Zebs
Still waiting for facts boy